#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Coxsackievirus B 3C Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling


The host innate immune response to viral infections often involves the activation of parallel pattern recognition receptor (PRR) pathways that converge on the induction of type I interferons (IFNs). Several viruses have evolved sophisticated mechanisms to attenuate antiviral host signaling by directly interfering with the activation and/or downstream signaling events associated with PRR signal propagation. Here we show that the 3Cpro cysteine protease of coxsackievirus B3 (CVB3) cleaves the innate immune adaptor molecules mitochondrial antiviral signaling protein (MAVS) and Toll/IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF) as a mechanism to escape host immunity. We found that MAVS and TRIF were cleaved in CVB3-infected cells in culture. CVB3-induced cleavage of MAVS and TRIF required the cysteine protease activity of 3Cpro, occurred at specific sites and within specialized domains of each molecule, and inhibited both the type I IFN and apoptotic signaling downstream of these adaptors. 3Cpro-mediated MAVS cleavage occurred within its proline-rich region, led to its relocalization from the mitochondrial membrane, and ablated its downstream signaling. We further show that 3Cpro cleaves both the N- and C-terminal domains of TRIF and localizes with TRIF to signalosome complexes within the cytoplasm. Taken together, these data show that CVB3 has evolved a mechanism to suppress host antiviral signal propagation by directly cleaving two key adaptor molecules associated with innate immune recognition.


Vyšlo v časopise: The Coxsackievirus B 3C Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling. PLoS Pathog 7(3): e32767. doi:10.1371/journal.ppat.1001311
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001311

Souhrn

The host innate immune response to viral infections often involves the activation of parallel pattern recognition receptor (PRR) pathways that converge on the induction of type I interferons (IFNs). Several viruses have evolved sophisticated mechanisms to attenuate antiviral host signaling by directly interfering with the activation and/or downstream signaling events associated with PRR signal propagation. Here we show that the 3Cpro cysteine protease of coxsackievirus B3 (CVB3) cleaves the innate immune adaptor molecules mitochondrial antiviral signaling protein (MAVS) and Toll/IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF) as a mechanism to escape host immunity. We found that MAVS and TRIF were cleaved in CVB3-infected cells in culture. CVB3-induced cleavage of MAVS and TRIF required the cysteine protease activity of 3Cpro, occurred at specific sites and within specialized domains of each molecule, and inhibited both the type I IFN and apoptotic signaling downstream of these adaptors. 3Cpro-mediated MAVS cleavage occurred within its proline-rich region, led to its relocalization from the mitochondrial membrane, and ablated its downstream signaling. We further show that 3Cpro cleaves both the N- and C-terminal domains of TRIF and localizes with TRIF to signalosome complexes within the cytoplasm. Taken together, these data show that CVB3 has evolved a mechanism to suppress host antiviral signal propagation by directly cleaving two key adaptor molecules associated with innate immune recognition.


Zdroje

1. O'NeillLA

BowieAG

2007 The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 353 364

2. KawaiT

TakahashiK

SatoS

CobanC

KumarH

2005 IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 981 988

3. MeylanE

CurranJ

HofmannK

MoradpourD

BinderM

2005 Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 1167 1172

4. XuLG

WangYY

HanKJ

LiLY

ZhaiZ

2005 VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 727 740

5. SethRB

SunL

EaCK

ChenZJ

2005 Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 669 682

6. DixitE

BoulantS

ZhangY

LeeAS

OdendallC

2010 Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141 668 681

7. LiXD

SunL

SethRB

PinedaG

ChenZJ

2005 Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102 17717 17722

8. YangY

LiangY

QuL

ChenZ

YiM

2007 Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A 104 7253 7258

9. ChenZ

BenureauY

RijnbrandR

YiJ

WangT

2007 GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81 964 976

10. DrahosJ

RacanielloVR

2009 Cleavage of IPS-1 in cells infected with human rhinovirus. J Virol 83 11581 11587

11. LiK

FoyE

FerreonJC

NakamuraM

FerreonAC

2005 Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102 2992 2997

12. MorensD

MaPM

1995 Human Enterovirus Infections; Rotbart HA, editor.

Washington D.C.

American Society for Microbiology

13. TracyS

ChapmanNM

McManusBM

PallanschMA

BeckMA

1990 A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22 403 414

14. BowlesNE

RichardsonPJ

OlsenEG

ArchardLC

1986 Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 1120 1123

15. MartinAB

WebberS

FrickerFJ

JaffeR

DemmlerG

1994 Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90 330 339

16. JinO

SoleMJ

ButanyJW

ChiaWK

McLaughlinPR

1990 Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82 8 16

17. WesselyR

KlingelK

KnowltonKU

KandolfR

2001 Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103 756 761

18. DeonarainR

CerulloD

FuseK

LiuPP

FishEN

2004 Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110 3540 3543

19. NegishiH

OsawaT

OgamiK

OuyangX

SakaguchiS

2008 A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A 105 20446 20451

20. RicherMJ

LavalleeDJ

ShaninaI

HorwitzMS

2009 Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4 e4127

21. KongL

SunL

ZhangH

LiuQ

LiuY

2009 An essential role for RIG-I in toll-like receptor-stimulated phagocytosis. Cell Host Microbe 6 150 161

22. GitlinL

BarchetW

GilfillanS

CellaM

BeutlerB

2006 Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103 8459 8464

23. RebsamenM

MeylanE

CurranJ

TschoppJ

2008 The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 15 1804 1811

24. ScottI

NorrisKL

2008 The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis. Biochem Biophys Res Commun 375 101 106

25. HuberSA

BuddRC

RossnerK

NewellMK

1999 Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy. Ann N Y Acad Sci 887 181 190

26. HenkeA

LaunhardtH

KlementK

StelznerA

ZellR

2000 Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74 4284 4290

27. LuoH

ZhangJ

CheungC

SuarezA

McManusBM

2003 Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol 163 381 385

28. NeznanovN

DragunskyEM

ChumakovKM

NeznanovaL

WekRC

2008 Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS One 3 e1887

29. BlomN

HansenJ

BlaasD

BrunakS

1996 Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci 5 2203 2216

30. LeeCC

KuoCJ

KoTP

HsuMF

TsuiYC

2009 Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem 284 7646 7655

31. YoneyamaM

KikuchiM

MatsumotoK

ImaizumiT

MiyagishiM

2005 Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175 2851 2858

32. LeiY

MooreCB

LiesmanRM

O'ConnorBP

BergstralhDT

2009 MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One 4 e5466

33. KaiserWJ

OffermannMK

2005 Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174 4942 4952

34. SahaSK

PietrasEM

HeJQ

KangJR

LiuSY

2006 Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25 3257 3263

35. FunamiK

SasaiM

OhbaY

OshiumiH

SeyaT

2007 Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J Immunol 179 6867 6872

36. FunamiK

SasaiM

OshiumiH

SeyaT

MatsumotoM

2008 Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation. J Biol Chem 283 18283 18291

37. JohnsenIB

NguyenTT

RingdalM

TryggestadAM

BakkeO

2006 Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 25 3335 3346

38. OshiumiH

MatsumotoM

FunamiK

AkazawaT

SeyaT

2003 TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4 161 167

39. YamamotoM

SatoS

MoriK

HoshinoK

TakeuchiO

2002 Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169 6668 6672

40. MeylanE

BurnsK

HofmannK

BlancheteauV

MartinonF

2004 RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5 503 507

41. ChoeSS

DoddDA

KirkegaardK

2005 Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337 18 29

42. WesselsE

DuijsingsD

LankeKH

van DoorenSH

JacksonCL

2006 Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol 80 11852 11860

43. SalakoMA

CarterMJ

KassGE

2006 Coxsackievirus protein 2BC blocks host cell apoptosis by inhibiting caspase-3. J Biol Chem 281 16296 16304

44. CampanellaM

de JongAS

LankeKW

MelchersWJ

WillemsPH

2004 The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca2+ homeostasis. J Biol Chem 279 18440 18450

45. ZaragozaC

SauraM

PadalkoEY

Lopez-RiveraE

LizarbeTR

2006 Viral protease cleavage of inhibitor of kappaBalpha triggers host cell apoptosis. Proc Natl Acad Sci U S A 103 19051 19056

46. CoyneCB

BergelsonJM

2006 Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 119 131

47. KallewaardNL

ZhangL

ChenJW

GuttenbergM

SanchezMD

2009 Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 6 91 98

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#